Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Research & Development (2020 - 2025)

INVO Fertility has reported Research & Development over the past 6 years, most recently at $127807.0 for Q2 2025.

  • Quarterly Research & Development changed N/A to $127807.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $777120.0 through Sep 2025, up 7104.23% year-over-year, with the annual reading at $388530.0 for FY2024, 134.13% up from the prior year.
  • Research & Development was $127807.0 for Q2 2025 at INVO Fertility, down from $265663.0 in the prior quarter.
  • Over five years, Research & Development peaked at $383650.0 in Q4 2024 and troughed at $2668.0 in Q3 2023.
  • The 5-year median for Research & Development is $73677.5 (2022), against an average of $106776.1.
  • Year-over-year, Research & Development tumbled 98.48% in 2023 and then skyrocketed 6394.84% in 2024.
  • A 5-year view of Research & Development shows it stood at $63756.0 in 2021, then grew by 15.81% to $73835.0 in 2022, then crashed by 92.0% to $5907.0 in 2023, then skyrocketed by 6394.84% to $383650.0 in 2024, then crashed by 66.69% to $127807.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Research & Development are $127807.0 (Q2 2025), $265663.0 (Q1 2025), and $383650.0 (Q4 2024).